– USA, NJ – Cantel Medical Corp. (NYSE: CMN) today announced the appointment of Dr. Ronnie Myers as a member of its Board of Directors, effective June 16.

Dr. Myers brings extensive experience to the Cantel Medical Board. On June 1, 2016, Dr. Myers began his appointment as Senior Associate Dean for Academic and Administrative Affairs at the newly established Touro College of Dental Medicine at New York Medical College. From January 2011 until June 2012 and then again from August 2013 until May 2016, Dr. Myers served as Vice Dean for Administration of Columbia University College of Dental Medicine. He served as Interim Dean of Columbia University College of Dental Medicine from July 2012 until July 2013. Dr. Myers first joined the Columbia faculty in 1982 as the Director of the General Practice Residency Program at New York Presbyterian Hospital. Dr. Myers maintained a private practice in general dentistry for 36 years and currently delivers lectures on the topic of infection prevention in the field of dentistry.

Dr. Myers is board qualified in pediatric dentistry. He obtained his dental degree in Pediatric Dentistry from Columbia University School of Dental and Oral Surgery, now the College of Dental Medicine, in 1980 and completed a fellowship in Pediatric Dentistry at the Albert Einstein College of Medicine from 1980-1981. Dr. Myers received his undergraduate degree from Syracuse University.

“We are pleased to have Dr. Myers join Cantel’s Board of Directors. His deep experience in dentistry and infection prevention, coupled with his practical experience, will make him a great addition to our Board and to the Company,” stated Charles M. Diker, Chairman of Cantel Medical.

About Cantel Medical

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products.

- DisclaimerNews, data and statement included in this release are intended exclusively for information purposes. Product and brand names used in this release maybe trademarks or registered trade marks of their respective owners. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of this release. No data or statement in this release should be considered a recommendation for the purchase, retention or sale of the securities referred to herein.

Talent4Boards Team

here the original post =>

Comments are closed.